RECRUITING

Neurobehavioral Therapy For Epilepsy And Major Depressive Disorder

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to examine the feasibility and acceptability of an online group Neuro-behavioral Therapy (NBT) with text messaging intervention for Veterans with epilepsy and major depressive disorder (MDD).

Official Title

Neurobehavioral Therapy For Epilepsy And Major Depressive Disorder

Quick Facts

Study Start:2024-12-19
Study Completion:2025-04-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06695767

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * English speaking veterans
  2. * has home internet access
  3. * has access to and familiarity in using a computer or tablet at least weekly
  4. * Asymptomatic patients with chronic conditions
  5. * has access to a mobile device with Short Message Service (SMS) text and picture capability
  6. * has an active clinical diagnosis of major depressive disorder based on the International Classification of Diseases, 10th version (ICD-10)
  7. * has an ICD-10 diagnosis of epilepsy with at least one seizure documented within the last five years
  1. * pregnancy
  2. * Veterans that have current suicidal ideation
  3. * have active psychosis; and have an ICD-10 diagnosis of psychogenic non-epileptic seizures or conversion disorder.

Contacts and Locations

Study Contact

Melissa Fadipe, MSN, APRN, FNP-C
CONTACT
(713) 825-7237
Melissa.F.Fadipe@uth.tmc.edu
Jennifer Beauchamp
CONTACT
(713) 500-2114
Jennifer.E.Beauchamp@uth.tmc.edu

Principal Investigator

Melissa Fadipe, MSN, APRN, FNP-C
PRINCIPAL_INVESTIGATOR
The University of Texas Health Science Center, Houston

Study Locations (Sites)

Michael E. DeBakey VA Medical Center
Houston, Texas, 77030
United States
The University of Texas health Science Center at Houston
Houston, Texas, 77030
United States

Collaborators and Investigators

Sponsor: The University of Texas Health Science Center, Houston

  • Melissa Fadipe, MSN, APRN, FNP-C, PRINCIPAL_INVESTIGATOR, The University of Texas Health Science Center, Houston

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-12-19
Study Completion Date2025-04-01

Study Record Updates

Study Start Date2024-12-19
Study Completion Date2025-04-01

Terms related to this study

Keywords Provided by Researchers

  • veterans

Additional Relevant MeSH Terms

  • Major Depressive Disorder
  • Epilepsy